Biotechnology company Debut has announced an agreement with L'Oréal to develop more than a dozen vital bioidentical ingredients that will replace conventionally sourced ingredients currently used in L'Oréal's global beauty and personal care brands across skin, hair, color and fragrance cosmetics.
As part of the agreement, Debut will leverage its proprietary biotechnology processes to create innovative bio-based ingredients. These advanced biomanufacturing methods, which integrate fermentation and cell-free technology, promise to transform conventional approaches to ingredient sourcing and production in the beauty industry.
“Creating bioidentical ingredients at scale helps preserve global biodiversity and ensure responsible ingredient supply chains while still prioritizing product quality and performance,” said Debut Founder and CEO Joshua Britton, Ph.D.
“Debut is committed to creating bio-based formulas for all of its beauty products and has unmatched capabilities in biotechnology, formulation and scaling to catalyze this transformative shift in beauty.”
The global beauty and personal care market is valued at $646 billion and is projected to grow at an annual rate of 3.33% according to Statista, creating an urgent need to source sustainable ingredients. L'Oréal says the partnership is a crucial step in its mission to develop more sustainable and effective products.
“Through this exciting partnership and the adoption of innovative technology, we are well positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfill our duty of care to the planet,” added Guive Balooch, Global General Manager, Augmented Beauty and Open Innovation at L’Oréal Groupe.
“This long-term agreement with Debut is another example of our commitment to the open innovation ecosystem and building the future of beauty by collaborating with best-in-class partners.”
Copyright © 2024 FashionNetwork.com All rights reserved.
